Found: 106
Select item for more details and to access through your institution.
Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2995, doi. 10.1093/jac/dkad344
- By:
- Publication type:
- Article
The burden of hospitalisations for COVID-19 in France: a study of all cases in the national insurance claims database in 2020.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2022.2160328
- By:
- Publication type:
- Article
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad525
- By:
- Publication type:
- Article
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 991, doi. 10.1093/cid/ciad297
- By:
- Publication type:
- Article
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2361, doi. 10.1093/jac/dkad247
- By:
- Publication type:
- Article
Cytokine profiles in adults with imported malaria.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36212-2
- By:
- Publication type:
- Article
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 5, p. 861, doi. 10.1093/cid/ciac827
- By:
- Publication type:
- Article
Monoclonal Antibodies in Hospitalised Patients with COVID-19: The Role of SARS-COV-2 Serostatus in an Evolving Pandemic.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 3, p. 735, doi. 10.1007/s40121-023-00769-2
- By:
- Publication type:
- Article
Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001-2019.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 12, p. 2367, doi. 10.3201/eid2812.220748
- By:
- Publication type:
- Article
Public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease.
- Published in:
- Journal of Market Access & Health Policy, 2022, v. 10, n. 1, p. 1, doi. 10.1080/20016689.2022.2082646
- By:
- Publication type:
- Article
Virus-Associated Nephropathies: A Narrative Review.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 12014, doi. 10.3390/ijms231912014
- By:
- Publication type:
- Article
Dolutegravir Monotherapy as Maintenance Strategy: A Meta-Analysis of Individual Participant Data From Randomized Controlled Trials.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 6, p. 1, doi. 10.1093/ofid/ofac107
- By:
- Publication type:
- Article
Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of Pneumocystis jirovecii Pneumonia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial.
- Published in:
- AIDS Research & Therapy, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12981-022-00428-5
- By:
- Publication type:
- Article
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.761250
- By:
- Publication type:
- Article
High Prevalence and High Rate of Antibiotic Resistance of Mycoplasma genitalium Infections in Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Pre-exposure Prophylaxis Trial.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. e2127, doi. 10.1093/cid/ciaa1832
- By:
- Publication type:
- Article
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Liver fibrosis and all‐cause mortality in chronic HCV‐infected diabetic patients: A paradoxical association? (ANRS CO22 HEPATHER).
- Published in:
- Liver International, 2021, v. 41, n. 7, p. 1694, doi. 10.1111/liv.14949
- By:
- Publication type:
- Article
No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of drug–drug interaction in an elderly human immunodeficiency virus population: Comparison of 3 expert databases.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1194, doi. 10.1111/bcp.14491
- By:
- Publication type:
- Article
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response.
- Published in:
- 2020
- By:
- Publication type:
- letter
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0234693
- By:
- Publication type:
- Article
Long-term Outcome of Patients With Nonoperated Prosthetic Valve Infective Endocarditis: Is Relapse the Main Issue?
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 5, p. 1316, doi. 10.1093/cid/ciz1177
- By:
- Publication type:
- Article
Lopinavir pharmacokinetics in COVID-19 patients.
- Published in:
- 2020
- By:
- Publication type:
- letter
Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 2, p. 293, doi. 10.1093/cid/ciz800
- By:
- Publication type:
- Article
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 50, n. 1, p. 211, doi. 10.1007/s11239-020-02146-z
- By:
- Publication type:
- Article
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Five-year follow-up of patients enrolled in the NEAT 001/ANRS 143 randomized clinical trial: NEAT 001/ANRS 143 LONG TERM study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1–positive individuals.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0230772
- By:
- Publication type:
- Article
Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV‐1 infection: results from a longitudinal study in the French ANRS Primo cohort.
- Published in:
- Journal of the International AIDS Society, 2020, v. 23, n. 4, p. 1, doi. 10.1002/jia2.25485
- By:
- Publication type:
- Article
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate – emtricitabine for HIV pre‐exposure prophylaxis.
- Published in:
- Journal of the International AIDS Society, 2020, v. 23, n. 2, p. 1, doi. 10.1002/jia2.25420
- By:
- Publication type:
- Article
Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment.
- Published in:
- Journal of the International AIDS Society, 2020, v. 23, n. 2, p. 1, doi. 10.1002/jia2.25443
- By:
- Publication type:
- Article
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 9, p. 1498, doi. 10.1093/cid/ciy1132
- By:
- Publication type:
- Article
Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study-authors' response.
- Published in:
- 2019
- By:
- Publication type:
- letter
Listeria Endophthalmitis Cured With Linezolid in an Immunocompetent Farmer Woman: Hazard of a Sweep of a Cow's Tail.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 11, p. N.PAG, doi. 10.1093/ofid/ofz459
- By:
- Publication type:
- Article
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Community-Based Care in the ANRS-IPERGAY Trial: The Challenges of Combination Prevention.
- Published in:
- AIDS Education & Prevention, 2019, v. 31, n. 3, p. 259, doi. 10.1521/aeap.2019.31.3.259
- By:
- Publication type:
- Article
Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS‐163 ETRAL Study
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 4, p. 514, doi. 10.1002/phar.2242
- By:
- Publication type:
- Article
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 597, doi. 10.1093/cid/ciy505
- By:
- Publication type:
- Article
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0211286
- By:
- Publication type:
- Article
Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS‐165 DARULIGHT study.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 11, p. N.PAG, doi. 10.1093/ofid/ofy295
- By:
- Publication type:
- Article
Hepatitis C virus incidence in HIV‐infected and in preexposure prophylaxis (PrEP)‐using men having sex with men.
- Published in:
- Liver International, 2018, v. 38, n. 10, p. 1736, doi. 10.1111/liv.13922
- By:
- Publication type:
- Article
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.
- Published in:
- 2018
- By:
- Publication type:
- journal article